As CEO of Charles River Laboratories, James C. Foster has seen significant changes in his financial holdings, reflecting the company's overall performance. His personal investment in the company has spiked at times, peaking at approximately $110.32 million in September 2021....

As CEO of Charles River Laboratories, James C. Foster has seen significant changes in his financial holdings, reflecting the company's overall performance. His personal investment in the company has spiked at times, peaking at approximately $110.32 million in September 2021. This shows his strong belief in the company's growth potential. In the past few years, the value of his holdings has fluctuated based on market conditions and company performance. In 2023, his holdings were roughly around $49.44 million. Earlier in 2020 and 2021, he witnessed a continuous rise in values that marked an exceptional financial period for the company. This fluctuation illustrates the dynamic nature of leadership roles in competitive sectors like life sciences.